PDF
ePub
Citation
Print
Sangha Kim, MD
, Kyoung-Uk Lee, MD
, Kyoung-Uk Lee, MD
Abstract
Suicide is a complex phenomenon resulting from interactions between individual vulnerabilities and socio-environmental factors. The current review primarily focuses on research into the serotonin system, hypothalamic-pituitary-adrenal axis, neurotrophic factors, lipid metabolism, and functional neuroimaging studies. It has been found that dysfunctions in the serotonin system, hypothalamic-pituitary-adrenal axis abnormalities, and low brain-derived neurotrophic factor and cholesterol levels may be linked to suicide. Additionally, recent neuroimaging studies have suggested that structural and functional abnormalities in brain areas related to cognitive and emotional regulation may be associated with suicide. More research incorporating advanced methodological approaches may shed further light on the neurobiological basis of suicide.
References
1. World Health Organization. Suicide data [Internet]. Geneva: World Health Organization;2018. cited 2019 Jan 4. Available from: https://www.who.int/mental_health/prevention/suicide/suicideprevent/en/.
2. Korea Suicide Prevention Center. Suicide rate for the last 10 years [Internet]. Seoul: Korea Suicide Prevention Center;2018. cited 2019 Jan 4. Available from: http://spckorea-stat.or.kr/korea01.do.
3. Gramaglia C, Feggi A, Bergamasco P, Bert F, Gattoni E, Marangon D, Siliquini R, Torre E, Zeppegno P. Clinical characteristics associated with suicide attempts in clinical settings: a comparison of suicidal and non-suicidal depressed inpatients. Front Psychiatry. 2016; 7:109.
4. Bachmann S. Epidemiology of suicide and the psychiatric perspective. Int J Environ Res Public Health. 2018; 15.
5. Fu Q, Heath AC, Bucholz KK, Nelson EC, Glowinski AL, Goldberg J, Lyons MJ, Tsuang MT, Jacob T, True MR, Eisen SA. A twin study of genetic and environmental influences on suicidality in men. Psychol Med. 2002; 32:11–24.
6. Mann JJ, Arango V, Underwood MD. Serotonin and suicidal behavior. Ann N Y Acad Sci. 1990; 600:476–484.
7. Bach H, Huang YY, Underwood MD, Dwork AJ, Mann JJ, Arango V. Elevated serotonin and 5-HIAA in the brainstem and lower serotonin turnover in the prefrontal cortex of suicides. Synapse. 2014; 68:127–130.
8. Asberg M, Traskman L. Studies of CSF 5-HIAA in depression and suicidal behaviour. Adv Exp Med Biol. 1981; 133:739–752.
9. Lester D. The concentration of neurotransmitter metabolites in the cerebrospinal fluid of suicidal individuals: a meta-analysis. Pharmacopsychiatry. 1995; 28:45–50.
10. Alvarez JC, Cremniter D, Lesieur P, Gregoire A, Gilton A, Macquin-Mavier I, Jarreau C, Spreux-Varoquaux O. Low blood cholesterol and low platelet serotonin levels in violent suicide attempters. Biol Psychiatry. 1999; 45:1066–1069.
11. Roggenbach J, Muller-Oerlinghausen B, Franke L, Uebelhack R, Blank S, Ahrens B. Peripheral serotonergic markers in acutely suicidal patients. 1. Comparison of serotonergic platelet measures between suicidal individuals, nonsuicidal patients with major depression and healthy subjects. J Neural Transm (Vienna). 2007; 114:479–487.
12. Mann JJ, McBride PA, Anderson GM, Mieczkowski TA. Platelet and whole blood serotonin content in depressed inpatients: correlations with acute and life-time psychopathology. Biol Psychiatry. 1992; 32:243–257.
13. Arango V, Underwood MD, Gubbi AV, Mann JJ. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res. 1995; 688:121–133.
14. Mann JJ, Huang YY, Underwood MD, Kassir SA, Oppenheim S, Kelly TM, Dwork AJ, Arango V. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry. 2000; 57:729–738.
15. Miller JM, Hesselgrave N, Ogden RT, Sullivan GM, Oquendo MA, Mann JJ, Parsey RV. Positron emission tomography quantification of serotonin transporter in suicide attempters with major depressive disorder. Biol Psychiatry. 2013; 74:287–295.
16. Marazziti D, Dell'Osso L, Rossi A, Masala I, Baroni S, Armani A, Giannaccini G, Di Nasso E, Lucacchini A, Cassano GB. Decreased platelet [3H]paroxetine binding sites in suicide attempters. Psychiatry Res. 2001; 103:125–131.
17. Roy A. Suicidal behavior in depression: relationship to platelet serotonin transporter. Neuropsychobiology. 1999; 39:71–75.
18. Boldrini M, Underwood MD, Mann JJ, Arango V. Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicides. J Psychiatr Res. 2008; 42:433–442.
19. Arango V, Underwood MD, Boldrini M, Tamir H, Kassir SA, Hsiung S, Chen JJ, Mann JJ. Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology. 2001; 25:892–903.
20. Stockmeier CA, Shapiro LA, Dilley GE, Kolli TN, Friedman L, Rajkowska G. Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity. J Neurosci. 1998; 18:7394–7401.
21. Pandey GN, Dwivedi Y, Rizavi HS, Ren X, Pandey SC, Pesold C, Roberts RC, Conley RR, Tamminga CA. Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims. Am J Psychiatry. 2002; 159:419–429.
22. Turecki G, Briere R, Dewar K, Antonetti T, Lesage AD, Seguin M, Chawky N, Vanier C, Alda M, Joober R, Benkelfat C, Rouleau GA. Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide. Am J Psychiatry. 1999; 156:1456–1458.
23. Hrdina PD, Demeter E, Vu TB, Sotonyi P, Palkovits M. 5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala. Brain Res. 1993; 614:37–44.
24. Pandey GN, Dwivedi Y, Ren X, Rizavi HS, Faludi G, Sarosi A, Palkovits M. Regional distribution and relative abundance of serotonin(2c) receptors in human brain: effect of suicide. Neurochem Res. 2006; 31:167–176.
25. Marion S, Weiner DM, Caron MG. RNA editing induces variation in desensitization and trafficking of 5-hydroxytryptamine 2c receptor isoforms. J Biol Chem. 2004; 279:2945–2954.
26. Lyddon R, Dwork AJ, Keddache M, Siever LJ, Dracheva S. Serotonin 2c receptor RNA editing in major depression and suicide. World J Biol Psychiatry. 2013; 14:590–601.
27. Dracheva S, Patel N, Woo DA, Marcus SM, Siever LJ, Haroutunian V. Increased serotonin 2C receptor mRNA editing: a possible risk factor for suicide. Mol Psychiatry. 2008; 13:1001–1010.
28. Carroll BJ. The dexamethasone suppression test for melancholia. Br J Psychiatry. 1982; 140:292–304.
29. Dumser T, Barocka A, Schubert E. Weight of adrenal glands may be increased in persons who commit suicide. Am J Forensic Med Pathol. 1998; 19:72–76.
30. Merali Z, Kent P, Du L, Hrdina P, Palkovits M, Faludi G, Poulter MO, Bedard T, Anisman H. Corticotropin-releasing hormone, arginine vasopressin, gastrin-releasing peptide, and neuromedin B alterations in stress-relevant brain regions of suicides and control subjects. Biol Psychiatry. 2006; 59:594–602.
31. Merali Z, Du L, Hrdina P, Palkovits M, Faludi G, Poulter MO, Anisman H. Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region. J Neurosci. 2004; 24:1478–1485.
32. Norman WH, Brown WA, Miller IW, Keitner GI, Overholser JC. The dexamethasone suppression test and completed suicide. Acta Psychiatr Scand. 1990; 81:120–125.
33. Roy A. Hypothalamic-pituitary-adrenal axis function and suicidal behavior in depression. Biol Psychiatry. 1992; 32:812–816.
34. Heim C, Newport DJ, Heit S, Graham YP, Wilcox M, Bonsall R, Miller AH, Nemeroff CB. Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA. 2000; 284:592–597.
35. Chatzittofis A, Nordstrom P, Hellstrom C, Arver S, Asberg M, Jokinen J. CSF 5-HIAA, cortisol and DHEAS levels in suicide attempters. Eur Neuropsychopharmacol. 2013; 23:1280–1287.
36. Jokinen J, Nordstrom P. HPA axis hyperactivity and attempted suicide in young adult mood disorder inpatients. J Affect Disord. 2009; 116:117–120.
37. Jokinen J, Martensson B, Nordstrom AL, Nordstrom P. CSF 5-HIAA and DST non-suppression-independent biomarkers in suicide attempters. J Affect Disord. 2008; 105:241–245.
38. Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci. 2001; 24:677–736.
39. Karege F, Vaudan G, Schwald M, Perroud N, La Harpe R. Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Res Mol Brain Res. 2005; 136:29–37.
40. Kim YK, Lee HP, Won SD, Park EY, Lee HY, Lee BH, Lee SW, Yoon D, Han C, Kim DJ, Choi SH. Low plasma BDNF is associated with suicidal behavior in major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2007; 31:78–85.
41. Lee BH, Kim YK. BDNF mRNA expression of peripheral blood mononuclear cells was decreased in depressive patients who had or had not recently attempted suicide. J Affect Disord. 2010; 125:369–373.
42. Middlemas DS, Lindberg RA, Hunter T. trkB, a neural receptor protein-tyrosine kinase: evidence for a full-length and two truncated receptors. Mol Cell Biol. 1991; 11:143–153.
43. Pandey GN, Ren X, Rizavi HS, Conley RR, Roberts RC, Dwivedi Y. Brain-derived neurotrophic factor and tyrosine kinase B receptor signalling in post-mortem brain of teenage suicide victims. Int J Neuropsychopharmacol. 2008; 11:1047–1061.
44. Ernst C, Deleva V, Deng X, Sequeira A, Pomarenski A, Klempan T, Ernst N, Quirion R, Gratton A, Szyf M, Turecki G. Alternative splicing, methylation state, and expression profile of tropomyosin-related kinase B in the frontal cortex of suicide completers. Arch Gen Psychiatry. 2009; 66:22–32.
45. Keller S, Sarchiapone M, Zarrilli F, Videtic A, Ferraro A, Carli V, Sacchetti S, Lembo F, Angiolillo A, Jovanovic N, Pisanti F, Tomaiuolo R, Monticelli A, Balazic J, Roy A, Marusic A, Cocozza S, Fusco A, Bruni CB, Castaldo G, Chiariotti L. Increased BDNF promoter methylation in the Wernicke area of suicide subjects. Arch Gen Psychiatry. 2010; 67:258–267.
46. Ernst C, Chen ES, Turecki G. Histone methylation and decreased expression of TrkB.T1 in orbital frontal cortex of suicide completers. Mol Psychiatry. 2009; 14:830–832.
47. Mauch DH, Nagler K, Schumacher S, Goritz C, Muller EC, Otto A, Pfrieger FW. CNS synaptogenesis promoted by glia-derived cholesterol. Science. 2001; 294:1354–1357.
48. Ellison LF, Morrison HI. Low serum cholesterol concentration and risk of suicide. Epidemiology. 2001; 12:168–172.
49. Partonen T, Haukka J, Virtamo J, Taylor PR, Lonnqvist J. Association of low serum total cholesterol with major depression and suicide. Br J Psychiatry. 1999; 175:259–262.
50. Lee BH, Kim YK. Potential peripheral biological predictors of suicidal behavior in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2011; 35:842–847.
51. Steegmans PH, Hoes AW, Bak AA, van der Does E, Grobbee DE. Higher prevalence of depressive symptoms in middle-aged men with low serum cholesterol levels. Psychosom Med. 2000; 62:205–211.
52. Perez-Rodriguez MM, Baca-Garcia E, Diaz-Sastre C, Garcia-Resa E, Ceverino A, Saiz-Ruiz J, Oquendo MA, de Leon J. Low serum cholesterol may be associated with suicide attempt history. J Clin Psychiatry. 2008; 69:1920–1927.
53. Kunugi H, Takei N, Aoki H, Nanko S. Low serum cholesterol in suicide attempters. Biol Psychiatry. 1997; 41:196–200.
54. Atmaca M, Kuloglu M, Tezcan E, Ustundag B. Serum leptin and cholesterol values in violent and non-violent suicide attempters. Psychiatry Res. 2008; 158:87–91.
55. Baek JH, Kang ES, Fava M, Mischoulon D, Nierenberg AA, Yu BH, Lee D, Jeon HJ. Serum lipids, recent suicide attempt and recent suicide status in patients with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2014; 51:113–118.
56. da Graca Cantarelli M, Nardin P, Buffon A, Eidt MC, Antonio Godoy L, Fernandes BS, Goncalves CA. Serum triglycerides, but not cholesterol or leptin, are decreased in suicide attempters with mood disorders. J Affect Disord. 2015; 172:403–409.
57. Markianos M, Koutsis G, Evangelopoulos ME, Sfagos C. Serum total cholesterol correlates positively to central serotonergic turnover in male but not in female subjects. Prog Neuropsychopharmacol Biol Psychiatry. 2010; 34:527–531.
58. Wallner B, Machatschke IH. The evolution of violence in men: the function of central cholesterol and serotonin. Prog Neuropsychopharmacol Biol Psychiatry. 2009; 33:391–397.
59. Martinowich K, Lu B. Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology. 2008; 33:73–83.
60. Monkul ES, Hatch JP, Nicoletti MA, Spence S, Brambilla P, Lacerda AL, Sassi RB, Mallinger AG, Keshavan MS, Soares JC. Fronto-limbic brain structures in suicidal and non-suicidal female patients with major depressive disorder. Mol Psychiatry. 2007; 12:360–366.
61. Ding Y, Lawrence N, Olie E, Cyprien F, le Bars E, Bonafe A, Phillips ML, Courtet P, Jollant F. Prefrontal cortex markers of suicidal vulnerability in mood disorders: a model-based structural neuroimaging study with a translational perspective. Transl Psychiatry. 2015; 5:e516.
62. Gosnell SN, Velasquez KM, Molfese DL, Molfese PJ, Madan A, Fowler JC, Christopher Frueh B, Baldwin PR, Salas R. Prefrontal cortex, temporal cortex, and hippocampus volume are affected in suicidal psychiatric patients. Psychiatry Res Neuroimaging. 2016; 256:50–56.
63. Hwang JP, Lee TW, Tsai SJ, Chen TJ, Yang CH, Lirng JF, Tsai CF. Cortical and subcortical abnormalities in late-onset depression with history of suicide attempts investigated with MRI and voxel-based morphometry. J Geriatr Psychiatry Neurol. 2010; 23:171–184.
64. Lee YJ, Kim S, Gwak AR, Kim SJ, Kang SG, Na KS, Son YD, Park J. Decreased regional gray matter volume in suicide attempters compared to suicide non-attempters with major depressive disorders. Compr Psychiatry. 2016; 67:59–65.
65. Gifuni AJ, Ding Y, Olie E, Lawrence N, Cyprien F, Le Bars E, Bonafe A, Phillips ML, Courtet P, Jollant F. Subcortical nuclei volumes in suicidal behavior: nucleus accumbens may modulate the lethality of acts. Brain Imaging Behav. 2016; 10:96–104.
66. Cyprien F, Courtet P, Malafosse A, Maller J, Meslin C, Bonafe A, Le Bars E, de Champfleur NM, Ritchie K, Artero S. Suicidal behavior is associated with reduced corpus callosum area. Biol Psychiatry. 2011; 70:320–326.
67. Olvet DM, Peruzzo D, Thapa-Chhetry B, Sublette ME, Sullivan GM, Oquendo MA, Mann JJ, Parsey RV. A diffusion tensor imaging study of suicide attempters. J Psychiatr Res. 2014; 51:60–67.
68. Jia Z, Wang Y, Huang X, Kuang W, Wu Q, Lui S, Sweeney JA, Gong Q. Impaired frontothalamic circuitry in suicidal patients with depression revealed by diffusion tensor imaging at 3.0 T. J Psychiatry Neurosci. 2014; 39:170–177.
69. Bijttebier S, Caeyenberghs K, van den Ameele H, Achten E, Rujescu D, Titeca K, van Heeringen C. The vulnerability to suicidal behavior is associated with reduced connectivity strength. Front Hum Neurosci. 2015; 9:632.
70. Kang SG, Na KS, Choi JW, Kim JH, Son YD, Lee YJ. Resting-state functional connectivity of the amygdala in suicide attempters with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2017; 77:222–227.
71. Fan T, Wu X, Yao L, Dong J. Abnormal baseline brain activity in suicidal and non-suicidal patients with major depressive disorder. Neurosci Lett. 2013; 534:35–40.
72. Cao J, Chen X, Chen J, Ai M, Gan Y, Wang W, Lv Z, Zhang S, Zhang S, Wang S, Kuang L, Fang W. Resting-state functional MRI of abnormal baseline brain activity in young depressed patients with and without suicidal behavior. J Affect Disord. 2016; 205:252–263.
73. Jollant F, Lawrence NS, Giampietro V, Brammer MJ, Fullana MA, Drapier D, Courtet P, Phillips ML. Orbitofrontal cortex response to angry faces in men with histories of suicide attempts. Am J Psychiatry. 2008; 165:740–748.
74. Jollant F, Lawrence NS, Olie E, O’Daly O, Malafosse A, Courtet P, Phillips ML. Decreased activation of lateral orbitofrontal cortex during risky choices under uncertainty is associated with disadvantageous decision-making and suicidal behavior. Neuroimage. 2010; 51:1275–1281.
75. Dombrovski AY, Szanto K, Clark L, Reynolds CF, Siegle GJ. Reward signals, attempted suicide, and impulsivity in late-life depression. JAMA Psychiatry. 2013; 70:1.
76. Pan LA, Batezati-Alves SC, Almeida JR, Segreti A, Akkal D, Hassel S, Lakdawala S, Brent DA, Phillips ML. Dissociable patterns of neural activity during response inhibition in depressed adolescents with and without suicidal behavior. J Am Acad Child Adolesc Psychiatry. 2011; 50:602–611.
77. Pan L, Segreti A, Almeida J, Jollant F, Lawrence N, Brent D, Phillips M. Preserved hippocampal function during learning in the context of risk in adolescent suicide attempt. Psychiatry Res. 2013; 211:112–118.
78. Ding Y, Pereira F, Hoehne A, Beaulieu MM, Lepage M, Turecki G, Jollant F. Altered brain processing of decision-making in healthy first-degree biological relatives of suicide completers. Mol Psychiatry. 2017; 22:1149–1154.
79. Pan LA, Hassel S, Segreti AM, Nau SA, Brent DA, Phillips ML. Differential patterns of activity and functional connectivity in emotion processing neural circuitry to angry and happy faces in adolescents with and without suicide attempt. Psychol Med. 2013; 43:2129–2142.
80. Olie E, Ding Y, Le Bars E, de Champfleur NM, Mura T, Bonafe A, Courtet P, Jollant F. Processing of decision-making and social threat in patients with history of suicidal attempt: a neuroimaging replication study. Psychiatry Res. 2015; 234:369–377.
81. Groschwitz RC, Plener PL, Groen G, Bonenberger M, Abler B. Differential neural processing of social exclusion in adolescents with non-suicidal self-injury: an fMRI study. Psychiatry Res Neuroimaging. 2016; 255:43–49.
82. Olie E, Jollant F, Deverdun J, de Champfleur NM, Cyprien F, Le Bars E, Mura T, Bonafe A, Courtet P. The experience of social exclusion in women with a history of suicidal acts: a neuroimaging study. Sci Rep. 2017; 7:89.
XML Download